Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders (Q34624766)
Jump to navigation
Jump to search
scientific article published on October 29, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders |
scientific article published on October 29, 2010 |
Statements
1 reference
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders (English)
1 reference
L. S. GOODMAN
1 September 1946
1 reference
1 reference
132
1 reference
126-132
1 reference
Identifiers
1 reference
1 reference